48,830
edits
(→Molecular pathology: format) |
(+list) |
||
Line 1: | Line 1: | ||
This article covers '''fibroblastic/myofibroblastic tumours'''. These tumours fit into the larger category of [[soft tissue lesions]]. | This article covers '''fibroblastic/myofibroblastic tumours'''. These tumours fit into the larger category of [[soft tissue lesions]]. | ||
==List of tumours== | |||
===Benign=== | |||
WHO classification:<ref name=Ref_WMSP601>{{Ref WMSP|601}}</ref> | |||
*[[Nodular fasciitis]]. | |||
*Proliferative fasciitis. | |||
*Proliferative myositis. | |||
*[[Myositis ossificans]]. | |||
*Ischemic fasciitis. | |||
*Elastofibroma. | |||
*Myofibroma. | |||
*Fibromatosis coli. | |||
*Inclusion body fibromatosis. | |||
*Fibroma of tendon sheath. | |||
*Calcifying aponeurotic fibroma. | |||
*Angiomyofbiroblstoma. | |||
*Cellular angiofibroma. | |||
*Nuchal-type fibroma. | |||
*Gardner fibroma. | |||
*Calcifying fibrous tumour. | |||
*Giant cell angiofibroma. | |||
*Fibrous hamartoma of infancy. | |||
*Juvenile hyaline fibromatosis. | |||
*Desmoplastic fibroblastoma. | |||
*Mammary-type myofibroblastoma. | |||
===Locally aggressive=== | |||
WHO classification:<ref name=Ref_WMSP601>{{Ref WMSP|601}}</ref> | |||
*Superfical fibromatosis. | |||
*[[Desmoid-type fibromatosis]]. | |||
*Lipofibromatosis. | |||
===Occasionally metastasizing=== | |||
WHO classification:<ref name=Ref_WMSP602>{{Ref WMSP|602}}</ref> | |||
*[[Solitary fibrous tumour]]. | |||
*[[Inflammatory myofibroblastic tumour]]. | |||
*Low-grad myofibroblastic sarcoma. | |||
*Myxoinflammatory fibroblastic sarcoma. | |||
*Infantile fibrosarcoma. | |||
===Malignant=== | |||
WHO classification:<ref name=Ref_WMSP602>{{Ref WMSP|602}}</ref> | |||
*Adult fibrosarcoma. | |||
*Myxofibrosarcoma. | |||
*[[Low-grade fibromyxoid sarcoma]] (hyalinizing spindle cell tumour). | |||
*Sclerosing epithelioid fibrosarcoma. | |||
==Inflammatory myofibroblastic tumour== | ==Inflammatory myofibroblastic tumour== |
edits